Skip to search formSkip to main contentSkip to account menu

Meningococcal Conjugate Vaccine MCV4

Known as: MCV4, Meningococcal Conjugate Vaccine MCV-4, Meningococcal Polysaccharide (Serogroups A, C, Y and W-135) Diphtheria Toxoid Conjugated Vaccine 
A conjugate vaccine of meningococcal polysaccharide used for active immunization against invasive meningococcal disease caused by Neisseria… 
National Institutes of Health

Related topics

Related topics

1 relation
Vaccines, Conjugate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
State-Level Voting Patterns and Adolescent Vaccination Coverage in the United States, 2014.
OBJECTIVES To examine state-level associations between voting patterns and adolescent coverage for at least 1 dose of human… 
Review
2012
Review
2012
Medicaid reimbursement and the uptake of adolescent vaccines.
2012
2012
Safety and Immunogenicity of a Meningococcal Quadrivalent Conjugate Vaccine in Five- to Eight-Year-Old Saudi Arabian Children Previously Vaccinated with Two Doses of a Meningococcal Quadrivalent…
ABSTRACT Saudi Arabian children respond poorly to 2 doses of meningococcal quadrivalent polysaccharide vaccine (MPSV4) when given… 
Review
2011
Review
2011
Vaccination Coverage among U.S. Adolescents Aged 13–17 Years Eligible for the Vaccines for Children Program, 2009
Objectives. We compared (1) characteristics of adolescents who are and are not entitled to receive free vaccines from the… 
Review
2010
Review
2010
Meningococcal conjugate vaccination among adolescents aged 13-17 years, United States, 2007.
2010
2010
MCV vaccination in the presence of vaccine-associated Guillain-Barré Syndrome risk: a decision analysis approach.
2008
2008
A distributed research network model for post‐marketing safety studies: the Meningococcal Vaccine Study
We describe a multi‐center post‐marketing safety study that uses distributed data methods to minimize the need for covered… 
2008
2008
Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease
Invasive meningococcal disease occurs worldwide causing an estimated 50,000–135,000 deaths each year in addition to significant… 
Review
2008
Review
2008
Meningococcal tetravalent conjugate vaccine
Background: Neisseria meningitidis is a leading cause of meningitis and sepsis worldwide. Since 1981, a tetravalent meningococcal… 
2006
2006
Inadvertent misadministration of meningococcal conjugate vaccine--United States, June-August 2005.
  • MMWR. Morbidity and mortality weekly report
  • 2006
  • Corpus ID: 23312301
During June-August 2005, CDC and the Food and Drug Administration (FDA) were notified of seven clusters of inadvertent… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)